Federal prosecutors last week leveled conspiracy and fraud charges against 2 former executives of Acclarent for an alleged off-label marketing scheme for the Relieva Stratus microflow spacer.
Former Acclarent CEO William Facteau and ex-sales vice president Patrick Fabian are accused of seeking to "quickly develop and market products to create a projected revenue stream that would make Acclarent an attractive target for either an initial public offering or acquisition," according to the U.S. Justice Dept. Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon paid $785 million for Acclarent back in 2010.
Help employers find you! Check out all the jobs and post your resume.
Former Acclarent CEO William Facteau and ex-sales vice president Patrick Fabian are accused of seeking to "quickly develop and market products to create a projected revenue stream that would make Acclarent an attractive target for either an initial public offering or acquisition," according to the U.S. Justice Dept. Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon paid $785 million for Acclarent back in 2010.
Help employers find you! Check out all the jobs and post your resume.
